Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
What is value investing? Discover the principles behind this strategy and how it can enhance your investment approach.
19,897 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Global equities outside the US have surged as growth improves and the dollar weakens. This article highlights three E...
Raymond James raises Marathon's target to 270, driven by sustained refining margins and strong MPLX distributions. MP...
Travel smarter, not pricier. These six frugal travel tips from frequent flyers reveal practical ways to trim costs on...
As companies seek sustainable productivity boosters in 2026, solo golf practice is gaining traction among executives....
SAP's chief executive says the AI race is being fought in the wrong place, stressing execution and operational contex...
This article breaks down egain (egan) 2026 earnings with a clear, data-driven view. We examine revenue drivers, margi...
Shopify beat expectations with robust 2025 results, while Amazon posted strong 2026 numbers, underscoring a clear spl...
A high-profile finale featuring Paul McCartney highlighted the financial calculus networks face as linear TV ad spend...
Is IBM stock a buy, hold, or sell in today’s market? This comprehensive stock analysis: sell? breaks down the busines...
A 68-year-old retiree taps a charitable remainder trust strategy to divest a $2.4 million concentrated stock position...
AI demand is reshaping semiconductors, putting Micron and Intel in the spotlight. This guide breaks down which could ...